A second Australian-developed and manufactured Covid-19 vaccine has surfaced with the University of Adelaide commencing human trials of its new vaccine that targets the highly-transmissible Omicron variant of the disease. Manufactured by Adelaide company BioCina, the university’s DNA-based vaccine is being trialled at Royal Adelaide Hospital in partnership with PARC Clinical Services and SA Pathology.…
By Peter Roberts Australian biotechnology and vaccine giant CSL is betting $800 million in the race to secure federal and state funding to establish mRNA vaccine in Australia. The company, which is the fourth most valuable company at $93 billion on the ASX, has outbid a group of smaller firms which are also seeking a…
The Victorian government has made a number of submissions to the federal government’s approach to market for a local mRNA vaccine manufacturing capability, with several other states also vying for Commonwealth support.
